TCRT has been on continuous publication since 2002. It is covered currently by all the major data systems such as Medline, PubMed, Web of Science, Thomson's ISI and SCI and Scopus.
The 2012 Impact factor for TCRT is 1.943
Cyberknife Radiosurgery for Squamous Cell Carcinoma of Vulva After Prior Pelvic Radiation Therapy (p. 375-380)
Limited options exist for patients experiencing a local recurrence of vulvar malignancies after surgery and pelvic radiation. These recurrences often are associated with cancer-related skin desquamation and poor clinical outcomes. A new radiotherapeutic treatment modality for the previously irradiated patient is cyberknife radiosurgery, which uses a linear accelerator mounted on an industrial robotic arm to allow non-coplanar radiation therapy delivery with sub-millimeter precision. This study describes the first reported use of cyberknife radiosurgery for the treatment of recurrent vulvar cancer in three women.
Key words: Vulvar cancer; Cyberknife radiosurgery.
TCRT October 2008
No. 5 (p 341-414)
Featured ImageIMRT or 3D-CRT in Glioblastoma? A Dosimetric Criterion for Patient Selection. Lorentini et al., Technol Cancer Res Treat 12(5), 411-420 (2013). www.tcrt.org/product-p-18047.html